Aclys

Developer of precision biologics for the treatment of cancer

placeLebanon, New Hampshire, United States calendar_todayFounded 2022 groups5 employees language aclys.bio

Registered entities

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon